Cogentix Medical (CGNT) Misses Q4 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Bernstein on Crypto: 'Clarity fails - what next?'
Cognyte Announces Fourth Quarter and Fiscal Year Ended January 31, 2022 Results
April 5, 2022 7:00 AM EDTHERZLIYA, Israel--(BUSINESS WIRE)-- Cognyte Software Ltd. (NASDAQ: CGNT) (the Company, Cognyte, we, us and our), a global leader in investigative analytics software, today announced results for the three months and year ended January 31, 2022 (Q4 FYE22 and FYE22).
In the fourth quarter, revenue was $125 million, up about $7 million sequentially from the third quarter, but several million dollars below the midpoint of our guidance. Our results reflect continued supply chain issues, as well as a lower conversion of our pipeline than we expected at the time of our last earnings conference call. We are proactively addressing these issues, but... More
